22-19353386-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_003325.4(HIRA):c.2818C>T(p.Leu940Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,612,986 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00016 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0000068 ( 0 hom. )
Consequence
HIRA
NM_003325.4 missense
NM_003325.4 missense
Scores
13
6
Clinical Significance
Conservation
PhyloP100: 7.23
Genes affected
HIRA (HGNC:4916): (histone cell cycle regulator) This gene encodes a histone chaperone that preferentially places the variant histone H3.3 in nucleosomes. Orthologs of this gene in yeast, flies, and plants are necessary for the formation of transcriptionally silent heterochomatin. This gene plays an important role in the formation of the senescence-associated heterochromatin foci. These foci likely mediate the irreversible cell cycle changes that occur in senescent cells. It is considered the primary candidate gene in some haploinsufficiency syndromes such as DiGeorge syndrome, and insufficient production of the gene may disrupt normal embryonic development. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 25 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HIRA | NM_003325.4 | c.2818C>T | p.Leu940Phe | missense_variant | 23/25 | ENST00000263208.5 | NP_003316.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HIRA | ENST00000263208.5 | c.2818C>T | p.Leu940Phe | missense_variant | 23/25 | 1 | NM_003325.4 | ENSP00000263208.5 | ||
HIRA | ENST00000340170.8 | c.2197C>T | p.Leu733Phe | missense_variant | 19/21 | 1 | ENSP00000345350.4 | |||
C22orf39 | ENST00000509549.5 | n.*2588C>T | non_coding_transcript_exon_variant | 23/24 | 2 | ENSP00000424903.1 | ||||
C22orf39 | ENST00000509549.5 | n.*2588C>T | 3_prime_UTR_variant | 23/24 | 2 | ENSP00000424903.1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152176Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
25
AN:
152176
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250866Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135706
GnomAD3 exomes
AF:
AC:
5
AN:
250866
Hom.:
AF XY:
AC XY:
4
AN XY:
135706
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460692Hom.: 0 Cov.: 32 AF XY: 0.00000826 AC XY: 6AN XY: 726646
GnomAD4 exome
AF:
AC:
10
AN:
1460692
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
726646
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000164 AC: 25AN: 152294Hom.: 1 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74466
GnomAD4 genome
AF:
AC:
25
AN:
152294
Hom.:
Cov.:
33
AF XY:
AC XY:
11
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 14, 2023 | The c.2818C>T (p.L940F) alteration is located in exon 23 (coding exon 23) of the HIRA gene. This alteration results from a C to T substitution at nucleotide position 2818, causing the leucine (L) at amino acid position 940 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
.;M
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Benign
T;D
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MutPred
0.61
.;Gain of methylation at R944 (P = 0.1562);
MVP
MPC
1.2
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at